NDC 0143-9859-01 - Ceftriaxone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9859
- Requested NDC
- 0143-9859-01
- Package NDCs from labels
- 0143-9859-01, 0143-9859-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2026-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CEFTRIAXONE FOR INJECTION, USP | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2026-09-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9859-01 | Ceftriaxone | 1 in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 1 | 17 | |
| 0143-9859-25 | Ceftriaxone | 25 in 1 BOX | INJECTION, POWDER, FOR SOLUTION | 25 | 17 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0143-9859 | CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [HIKMA PHARMACEUTICALS USA INC.] | 16 | Current NDC, Legacy NDC, 2 package rows | 20230312_8351aa37-552d-471d-b293-c564dcb6ec29.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9859-01 | EA - Each | 0143-9859 | 3f1588c2-0344-482a-a983-dd91a2e5585b | 1 | 2015-03-03 |
| 0143-9859-25 | EA - Each | 0143-9859 | e3a5b5e0-efe6-4b2d-ae9b-aafccbd60f94 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEFTRIAXONE SODIUM | ACTIVE INGREDIENT | 023Z5BR09K | CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICALS CORP] | 12 | |
| CEFTRIAXONE | ACTIVE MOIETY | 75J73V1629 | CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICALS CORP] | 12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | A-S Medication Solutions | 1aa0a4ee-1b39-4c3d-a7a3-33dded6fe28c | 2024-01-31 | Warnings, Adverse reactions | 309092 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | A-S Medication Solutions | ff8e830a-c288-46fb-9e19-ec2017943c07 | 2024-01-31 | Warnings, Adverse reactions | 309092 023Z5BR09K |
| ceftriaxone | CEFTRIAXONE | Sagent Pharmaceuticals | 5cf93bc5-9e4c-4734-bc02-c7d0ac071022 | 2023-11-08 | Warnings, Adverse reactions | 1665046 1665005 1665021 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE | Fresenius Kabi USA, LLC | 7ea1db43-40fa-417b-8911-ae98092070a0 | 2023-09-30 | Warnings, Adverse reactions | 1665046 1665005 1665021 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Asclemed USA, Inc. | f01cf0e5-caaf-4759-ba21-50f3aceff523 | 2023-09-02 | Warnings, Adverse reactions | 1665005 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Apotex Corp. | 5116231f-82d1-44be-b08e-560c9a50e5c5 | 2023-08-31 | Warnings, Adverse reactions | 1665046 1665005 309092 1665021 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Apotex Corp. | ac03a72c-0e35-40f9-b7fc-081badb5f19c | 2023-01-28 | Warnings, Adverse reactions | 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE SODIUM | Samson Medical Technologies, LLC | 5cd2d96f-83e5-4326-ae87-d0ede4ba493a | 2023-01-15 | Warnings, Adverse reactions | 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE | Proficient Rx LP | fcf401df-bcdc-4773-a63b-9741c0f74b3d | 2022-11-01 | Warnings, Adverse reactions | 1665046 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Proficient Rx LP | a25ab5ea-c46d-4562-8f7e-0ccffc2ab069 | 2022-10-01 | Warnings, Adverse reactions | 1665046 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Proficient Rx LP | 42ba7a9d-7d2b-4eac-af59-897151a8c924 | 2022-05-02 | Warnings, Adverse reactions | 1665021 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Hospira, Inc | 9d1f630b-e759-4395-9d01-ddc90e4fea75 | 2022-03-09 | Warnings, Adverse reactions | 1665046 1665021 023Z5BR09K |
| CEFTRIAXONE AND DEXTROSE | CEFTRIAXONE | B. Braun Medical Inc. | 67153914-16bc-490d-82d7-638061618467 | 2022-01-13 | Warnings, Adverse reactions | 1665046 1665021 023Z5BR09K |
| 22f5b167-43fa-4fdf-9687-506a02e372e5 | 8351aa37-552d-471d-b293-c564dcb6ec29 | 2021-12-01 | Warnings, Adverse reactions | 22f5b167-43fa-4fdf-9687-506a02e372e5 8351aa37-552d-471d-b293-c564dcb6ec29 | ||
| Ceftriaxone | CEFTRIAXONE | Hikma Pharmaceuticals USA Inc. | 1f8776bd-4f5b-427a-849a-6b8338f7997d | 2019-04-24 | Warnings, Adverse reactions | 023Z5BR09K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.